| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6117001 | Immunology Letters | 2016 | 30 Pages |
Abstract
This article reviews the rationale, clinical data, and toxicity profiles of immune therapies approved or in late stages of development for B-ALL.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Swati Sikaria, Ibrahim Aldoss, Mojtaba Akhtari,